Protamine-oligonucleotide-nanoparticles as depot formulation, targeting system and immune-modulator
Year: 2016
Type: dissertation
Abstract: Since biological structures are used as active pharmaceutical ingredients, the formulation of effective drug delivery systems has become an important field in pharmaceutical technology.Delivery systems are often designed according to the therapeutic needs of the applied API, in order to increase or modify the initial therapeutic response.Within the last 15 years, protamine-oligonucleotide-nanoparticles (proticles) were used as delivery system for different kinds of oligonucleotides (ODNs), siRNA and peptides.However, the possible development of individually designed proticles for defined applications has not been evaluated.In general, proticles consist of a modular assembly system, which show ideal properties for specified nanoparticulate formulations.The present thesis describes three possible aspects for preparation of individually assembled proticles.Thereby, a protamine titration process was developed in order to enable modification of the physicochemical properties.This process was integrated into the formation of secretoneurin (SN) loaded proticles and pointed out that through application of the titration process the particle size can be modified without influencing the SN loading capacity.Formulations, which show a high particle size and an initial depot effect, can serve as potential delivery system for the angiogenic neuropeptide SN.Further, IL-10 coating of fluorescently labelled proticles was performed in order to recognize atherosclerotic lesions followed by visualization.As IL-10 was used as targeting sequence and therapeutic peptide, this formulation shows promising results in the field of theranostics.As third aspect, the approach of multiple drug loading via proticles was evaluated through combined application of the major peanut allergen Ara h 2 and CpG-ODNs.Thereby, due to the application of CpG-ODNs the induced immune response could be driven towards Th1, which indicated a possible immunotherapy of allergy.ZAve (d.nm) Z-Average, mean hydrodynamic diameter in nanometer scale WB Western blot ZP zeta potentialAround 15 years ago, protamine-oligonucleotide-nanoparticles (so called proticles) were introduced as a drug delivery system for antisense-oligonucleotides (1).Thereby, the ability of protamines to condense short nucleotide fragments was used to form stable nanoparticles by self-assembly.In recent years, this formulation method was successfully applied as delivery system for different types of oligonucleotides, siRNA, thiomers and peptides.However, for the successful application as nanoparticulate drug delivery system several aspects have to be considered besides structural protection and sufficient API loading. Oligonucleotide sequences already used in proticle researchSo far, different types of nucleotides were assembled within proticles.Besides the initially used AS-ODNs, also siRNA and thiomers were successfully integrated into the proticle matrix.Different lengths of AS-ODNs were applied as well as sequences containing CpG motifs (CpG-ODNs).Thus, it could be revealed that proticle formation is whether restricted to a specified sequence nor a distinct chain length.Table 2 shows all ODN sequences, which were already used in proticle research.5 (1.8%) (28, 55) Parameters were computed with ProtParam tool of SIB ExPASy Bioinformatics Resources Portal (56).pI: isoelectric point (theoretical); 2 Protamine-oligonucleotide-nanoparticles: Recent advances in drug delivery and drug targeting
Author: Scheicher, Bernhard
Institution: University of Graz
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Funder: Austrian Science Fund
Awards: G2206262944, G2875424002, G2918408271
OpenAlex ID: W7005567675
